World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4227)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

123

WORD

HTML

2156

Figures (1-5)

316

Tables (1-4)

296

Sum=2892

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

198

Download

494

Sum=692

Publishing Process of This Article

Item

Count

Browse

114

Download

336

Sum=450

Mar 15, 2024 (publication date) through Apr 18, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Islam L, Jose D, Alkhalifah M, Blaibel D, Chandrabalan V, Pappachan JM. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience. World J Diabetes 2024; 15(3): 463-474 [PMID: 38591092 DOI: 10.4239/wjd.v15.i3.463]
URL:	https://www.wjgnet.com/2307-8960/full/v15/i3/463.htm

Number	Citing Articles
1	Oscar R. Zambrano-Vásquez, Fernando Cortes-Camacho, Jorge I. Castañeda-Sánchez, Elena Aréchaga-Ocampo, Estefanía Valle-Velázquez, Juan C. Cabrera-Angeles, José L. Sánchez-Gloria, Fausto Sánchez-Muñoz, Abraham S. Arellano-Buendia, Laura G. Sánchez-Lozada, Horacio Osorio-Alonso. Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors. Life Sciences 2025; : 123638 doi: 10.1016/j.lfs.2025.123638
2	Vanishri Ganakumar, Cornelius J Fernandez, Joseph M Pappachan. Antidiabetic combination therapy and cardiovascular outcomes: An evidence-based approach. World Journal of Diabetes 2025; 16(4): 102390 doi: 10.4239/wjd.v16.i4.102390 Abstract(144) \| Core Tip(129) \| Full Article(HTML)(598) \| Full Article with Cover (PDF)-2222K(57) \| Audio-569K(3) \| Peer-Review Report-303K(15) \| Answering Reviewers-103K(16) \| Full Article (PDF)-1976K(45) \| Full Article (XML)-160K(17) \| Times Cited (0) \| Total Visits (1667) \| Open
3	Sunetra Mondal, Subhodip Pramanik, Vibhu Ranjan Khare, Cornelius James Fernandez, Joseph M Pappachan. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World Journal of Cardiology 2024; 16(5): 240-259 doi: 10.4330/wjc.v16.i5.240 Abstract(496) \| Core Tip(423) \| Full Article(HTML)(2663) \| Full Article with Cover (PDF)-1054K(92) \| Audio-398K(6) \| Peer-Review Report-172K(40) \| Answering Reviewers-83K(47) \| Full Article (PDF)-799K(391) \| Full Article (XML)-316K(44) \| Times Cited (5) \| Total Visits (5336) \| Open
4	Canagliflozin. Reactions Weekly 2024; 2012(1): 91 doi: 10.1007/s40278-024-60754-3